TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Glycorex Transplantation AB (publ)
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
20,125
|
24,134
|
20,507 |
Financial expenses |
259
|
165
|
292 |
Earnings before taxes |
-20,395
|
-5,693
|
-8,901 |
EBITDA |
-6,004
|
166
|
-2,435 |
Total assets |
44,226
|
64,202
|
74,021 |
Current assets |
17,556
|
30,365
|
36,762 |
Current liabilities |
9,759
|
10,573
|
9,832 |
Equity capital |
29,580
|
49,692
|
60,318 |
- share capital |
2,480
|
2,467
|
2,685 |
Employees (average) |
23
|
22
|
24 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
66.9%
|
77.4%
|
81.5% |
Turnover per employee |
875
|
1,097
|
854 |
Profit as a percentage of turnover |
-101.3%
|
-23.6%
|
-43.4% |
Return on assets (ROA) |
-45.5%
|
-8.6%
|
-11.6% |
Current ratio |
179.9%
|
287.2%
|
373.9% |
Return on equity (ROE) |
-68.9%
|
-11.5%
|
-14.8% |
Change turnover |
-4,133
|
5,288
|
874 |
Change turnover % |
-17%
|
28%
|
4% |
Chg. No. of employees |
1
|
-2
|
2 |
Chg. No. of employees % |
5%
|
-8%
|
9% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.